Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal Carcinoma.

MLA

Hazini, Ahmet, et al. “Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal Carcinoma.” Human Gene Therapy, vol. 29, no. 11, Nov. 2018, pp. 1301–14. EBSCOhost, https://doi.org/10.1089/hum.2018.036.

APA

Hazini, A., Pryshliak, M., Brückner, V., Klingel, K., Sauter, M., Pinkert, S., Kurreck, J., & Fechner, H. (2018). Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal Carcinoma. Human Gene Therapy, 29(11), 1301–1314. https://doi.org/10.1089/hum.2018.036

Chicago

Hazini, Ahmet, Markian Pryshliak, Vanessa Brückner, Karin Klingel, Martina Sauter, Sandra Pinkert, Jens Kurreck, and Henry Fechner. 2018. “Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal Carcinoma.” Human Gene Therapy 29 (11): 1301–14. doi:10.1089/hum.2018.036.